Page last updated: 2024-10-21

gallopamil and Obesity

gallopamil has been researched along with Obesity in 2 studies

Gallopamil: Coronary vasodilator that is an analog of iproveratril (VERAPAMIL) with one more methoxy group on the benzene ring.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eberhardson, M1
Patterson, S1
Grapengiesser, E1
Auguet, M1
Delaflotte, S1
Braquet, P1

Other Studies

2 other studies available for gallopamil and Obesity

ArticleYear
Microfluorometric analysis of Cl- permeability and its relation to oscillatory Ca2+ signalling in glucose-stimulated pancreatic beta-cells.
    Cellular signalling, 2000, Volume: 12, Issue:11-12

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Anions; Calcium; Calcium Channel Blockers

2000
Increased influence of endothelium in obese Zucker rat aorta.
    The Journal of pharmacy and pharmacology, 1989, Volume: 41, Issue:12

    Topics: Animals; Aorta, Thoracic; Endothelium, Vascular; Gallopamil; Male; Muscle Contraction; Nitric Oxide;

1989